Galena Biopharma, Inc. 4
4 · Galena Biopharma, Inc. · Filed Dec 20, 2016
Insider Transaction Report
Form 4
Knapp Thomas J
General Counsel
Transactions
- Award
Stock Option (right to buy)
2016-10-25+102,000→ 102,000 totalExercise: $0.29Exp: 2026-10-25→ Common Stock (102,000 underlying)
Footnotes (3)
- [F1]Granted pursuant to the Issuer's 2016 Incentive Plan.
- [F2]The Reporting Person obtained the securities pursuant to an Employment Agreement Amendment dated October 1, 2016. The securities were convertible into common stock at the rate of 1 share of common stock for each 1 stock option share, or an aggregate of 102,000 shares of common stock (pre-reverse stock split). The securities were converted into 5,100 stock options at a price of $5.744 per share (post-reverse split) as of November 14, 2016.
- [F3]This stock option vests in equal monthly installments beginning November 25, 2016 and ending March 31, 2017.